We’ve been seeing some mean moves lately. Someone appointed to a high government post by President Trump states a position that is then undermined by the Commander-in-Chief. The appointee has to backtrack—picture Michael Jackson doing his moonwalk.
Excellent breakdown in the Wall Street Journal this morning about what we can describe (being only a tad hyperbolic) as the bombshell of a CBO report that landed last night. It says that the American Health Care Act, as passed by the House, would result in 23 million more Americans being uninsured.
All parties agree on this: A decision will need to be made soon. The Senate Health Care Working Group today met with Blue Cross Blue Shield officials to discuss what the Senate needs in its health care legislation to ensure that plans participate and offer affordable benefit packages, according to the Hill.
Sen. Lamar Alexander wants to save the ACA before killing it. That would be quite a trick, as Roll Call reports, but Alexander says that some aspects of the law should remain in place for 2018 and 2019.
The FDA yesterday ruled that Merck’s Keytruda (pembrolizumab) can be used for almost any solid tumors with one of two genetic abnormalities that have not responded to first-line treatment. It makes the drug the first to be given the status of first tissue/site-agnostic.
Some are using the word “cure” for chimeric antigen receptor T cells. The modular nature of CAR T cells could provide novel strategies to combat resistance and convert more initial complete responses into lasting complete responses. Problems include: cytokine release syndrome, resistance, and finding ways to produce them more efficiently.